No Data
No Data
Sidoti Events, LLC's Virtual August Micro-Cap Conference
Express News | Precision Biosciences Says Partner TG Therapeutics Gets U.S. FDA Clearance For Investigational New Drug (Ind) Application To Investigate Azercabtagene Zapreleucel (Azer-cel) In Human Clinical Trials For Multiple Sclerosis
Express News | Precision BioSciences Inc - TG Therapeutics Anticipates Commencing a Phase 1 Clinical Trial in 2024.
Express News | Precision BioSciences Announces Investigational New Drug Clearance by Partner TG Therapeutics for Investigation of Azer-Cel for Multiple Sclerosis
JonesTrading Maintains Precision BioSciences(DTIL.US) With Buy Rating, Maintains Target Price $30
Precision BioSciences: A Strong Buy on Forthcoming Clinical Milestones and Robust Financials
No Data
Boxman : This is another co. funded by Ven bio !!! Pretty nice